Lenalidomide, Bortezomib, and Dexamethasone (Rev/Vel/Dex) as Front-Line Therapy for Patients with Multiple Myeloma (MM): Preliminary Results of a Phase 1/2 Study.

Paul G. Richardson, Kenneth C. Anderson, Noopur Raje et al.|Blood|2007

Cited by 30